SCHEMBL7370282

SCHEMBL7370282

CCCCCCn1c(=O)c(-c2cc(O)c(O)c([N+](=O)[O-])c2)nc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CFTR P13569 7/20 0.56
ALDH1A1 P00352 4/20 0.47
NPSR1 Q6W5P4 2/20 0.47
CYP1A2 P05177 1/20 0.47
GLA P06280 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
TLR8 Q9NR97 2/20 0.47
IRAK4 Q9NWZ3 1/20 0.46
KDM4E B2RXH2 3/20 0.44
MAPT P10636 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
HTT P42858 1/20 0.43
SAE1 Q9UBE0 1/20 0.43
UBA2 Q9UBT2 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7371231 0.92 CFTR (0.65) CFTR
SCHEMBL7371972 0.83 ALDH1A1 (0.55) CFTRALDH1A1KDM4EMAPTRAB9A
SCHEMBL981153 0.73 CFTR (0.64) CFTRALDH1A1NPSR1CYP1A2GLA
SCHEMBL19032805 0.72 CFTR (1.00) CFTRIRAK4MAPT
SCHEMBL29497971 0.72 CFTR (1.00) CFTRIRAK4MAPT
SCHEMBL9318480 0.70 TLR8 (0.63) ALDH1A1NPSR1CYP1A2GLACYP2D6
SCHEMBL981905 0.69 KDM4E (0.55) CFTRALDH1A1NPSR1CYP1A2GLA
SCHEMBL982260 0.69 CFTR (0.55) CFTRALDH1A1NPSR1CYP1A2GLA
SCHEMBL13694766 0.68 CFTR (0.61) CFTRALDH1A1CYP1A2CYP2D6KDM4E
SCHEMBL10834022 0.68 TLR8 (0.68) ALDH1A1NPSR1CYP1A2GLACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed